Anti-™EM74 monoclonal antibody

Pre-made anti-™EM74 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM74/™EM74 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2126-Ab-1/ GM-Tg-hg-IP2126-Ab-2Anti-Human ™EM74 monoclonal antibodyHuman
GM-Tg-rg-IP2126-Ab-1/ GM-Tg-rg-IP2126-Ab-2Anti-Rat ™EM74 monoclonal antibodyRat
GM-Tg-mg-IP2126-Ab-1/ GM-Tg-mg-IP2126-Ab-2Anti-Mouse ™EM74 monoclonal antibodyMouse
GM-Tg-cynog-IP2126-Ab-1/ GM-Tg-cynog-IP2126-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM74 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2126-Ab-1/ GM-Tg-felg-IP2126-Ab-2Anti-Feline ™EM74 monoclonal antibodyFeline
GM-Tg-cang-IP2126-Ab-1/ GM-Tg-cang-IP2126-Ab-2Anti-Canine ™EM74 monoclonal antibodyCanine
GM-Tg-bovg-IP2126-Ab-1/ GM-Tg-bovg-IP2126-Ab-2Anti-Bovine ™EM74 monoclonal antibodyBovine
GM-Tg-equg-IP2126-Ab-1/ GM-Tg-equg-IP2126-Ab-2Anti-Equine ™EM74 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2126-Ab-1/ GM-Tg-hg-IP2126-Ab-2; GM-Tg-rg-IP2126-Ab-1/ GM-Tg-rg-IP2126-Ab-2;
GM-Tg-mg-IP2126-Ab-1/ GM-Tg-mg-IP2126-Ab-2; GM-Tg-cynog-IP2126-Ab-1/ GM-Tg-cynog-IP2126-Ab-2;
GM-Tg-felg-IP2126-Ab-1/ GM-Tg-felg-IP2126-Ab-2; GM-Tg-cang-IP2126-Ab-1/ GM-Tg-cang-IP2126-Ab-2;
GM-Tg-bovg-IP2126-Ab-1/ GM-Tg-bovg-IP2126-Ab-2; GM-Tg-equg-IP2126-Ab-1/ GM-Tg-equg-IP2126-Ab-2
Products NameAnti-™EM74 monoclonal antibody
Formatmab
Target Name™EM74
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM74 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2126-Ag-1Recombinant multi-species ™M74/ ™EM74/ NET36 protein
    ORF Viral VectorpGMLP004292human ™EM74 Lentivirus plasmid
    ORF Viral VectorvGMLP004292human ™EM74 Lentivirus particle
    ORF Viral VectorpGMLPm003349mouse Tmem74 Lentivirus plasmid
    ORF Viral VectorvGMLPm003349mouse Tmem74 Lentivirus particle


    Target information

    Target IDGM-IP2126
    Target Name™EM74
    Gene ID157753,239408,500864,698257,100682800,101088141,539995,100056570
    Gene Symbol and SynonymsB230382K22Rik,NET36,RGD1566279,™EM74
    Uniprot AccessionQ96NL1
    Uniprot Entry Name™M74_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000164841
    Target ClassificationN/A

    The target: ™EM74, gene name: ™EM74, also named as NET36. Involved in macroautophagy. Predicted to be located in autophagosome membrane; cytoplasmic vesicle; and lysosomal membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.